PixCelium – Investment Proposition

PixCelium is building the next-generation compliance platform for the MedTech industry, a market currently underserved by outdated, document-based quality systems. As regulations grow more complex and innovation accelerates, MedTech companies are under pressure to stay compliant without losing speed or clarity. PixCelium offers a breakthrough: a process-first, data-driven platform that makes compliance smarter, faster, and fully traceable from start to scale.

Our platform connects people, processes, and regulatory requirements into one living system, replacing fragmented documentation with structured, actionable data. This enables companies to reduce audit risk, accelerate product development, and operate with clarity across teams and tools. Powered by semantic modelling and process orchestration, PixCelium goes beyond eQMS tools by creating a fully integrated compliance backbone that evolves with its users.

What makes PixCelium different:

• Purpose-built for MedTech with deep domain alignment (ISO 13485, MDR, FDA)

• Scalable architecture that supports startups to enterprise

• Built-in traceability and audit readiness by design

• Semantic foundations that future-proof organisations for interoperability and AI-readiness

With four pilot customers onboarded, strong early traction from key industry players, and a clear roadmap to scale, PixCelium is poised to redefine compliance as a strategic asset, not a burden.

We’re now seeking strategic investors who resonate with our vision and want to help shape the future of compliance in MedTech. Join us in unlocking the next phase of intelligent, integrated compliance.